Clinical Trial Update: RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy [NA]

View source ↗

Summary

A clinical trial evaluating the RNA Disruption Assay (RDA) to assess breast cancer response and guide individualized therapy. The study status is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Rna Diagnostics Inc. | Conditions: Breast Neoplasm Female | NA | Status: RECRUITING